CBLC – Wikipedia
From Wikipedia, the free encyclopedia
Protein-coding gene in the species Homo sapiens
Signal transduction protein CBL-C is a protein that in humans is encoded by the CBLC gene.[5][6][7]
CBL proteins, such as CBLC, are phosphorylated upon activation of a variety of receptors that signal via protein tyrosine kinases. Through interactions with proteins containing SRC (MIM 190090) homology-2 (SH2) and SH3 domains, CBL proteins modulate downstream cell signaling (Keane et al., 1999).[supplied by OMIM][7]
Interactions[edit]
CBLC has been shown to interact with FYN[8] and Epidermal growth factor receptor.[6][9]
References[edit]
- ^ a b c GRCh38: Ensembl release 89: ENSG00000142273 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000040525 – Ensembl, May 2017
- ^ “Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ “Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J, Lipkowitz S (Jun 1999). “cbl-3: a new mammalian cbl family protein”. Oncogene. 18 (22): 3365–75. doi:10.1038/sj.onc.1202753. PMID 10362357.
- ^ a b Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M, Yamamoto T (Dec 1999). “Molecular cloning and characterization of a novel cbl-family gene, cbl-c”. Gene. 239 (1): 145–54. doi:10.1016/S0378-1119(99)00356-X. PMID 10571044.
- ^ a b “Entrez Gene: CBLC Cas-Br-M (murine) ecotropic retroviral transforming sequence c”.
- ^ Kim, M; Tezuka T; Suziki Y; Sugano S; Hirai M; Yamamoto T (Oct 1999). “Molecular cloning and characterization of a novel cbl-family gene, cbl-c”. Gene. NETHERLANDS. 239 (1): 145–54. doi:10.1016/S0378-1119(99)00356-X. ISSN 0378-1119. PMID 10571044.
- ^ Keane, M M; Ettenberg S A; Nau M M; Banerjee P; Cuello M; Penninger J; Lipkowitz S (Jun 1999). “cbl-3: a new mammalian cbl family protein”. Oncogene. ENGLAND. 18 (22): 3365–75. doi:10.1038/sj.onc.1202753. ISSN 0950-9232. PMID 10362357.
External links[edit]
Further reading[edit]
- Ollendorff V, Mattei M, Fournier E, et al. (1999). “A third human CBL gene is on chromosome 19”. Int. J. Oncol. 13 (6): 1159–61. doi:10.3892/ijo.13.6.1159. PMID 9824625.
- Irby RB, Mao W, Coppola D, et al. (1999). “Activating SRC mutation in a subset of advanced human colon cancers”. Nat. Genet. 21 (2): 187–90. doi:10.1038/5971. PMID 9988270. S2CID 27129630.
- Ettenberg SA, Keane MM, Nau MM, et al. (1999). “Cbl-b inhibits epidermal growth factor receptor signaling”. Oncogene. 18 (10): 1855–66. doi:10.1038/sj.onc.1202499. PMID 10086340.
- Loreto MP, Berry DM, McGlade CJ (2002). “Functional Cooperation between c-Cbl and Src-Like Adaptor Protein 2 in the Negative Regulation of T-Cell Receptor Signaling”. Mol. Cell. Biol. 22 (12): 4241–55. doi:10.1128/MCB.22.12.4241-4255.2002. PMC 133880. PMID 12024036.
- Szymkiewicz I, Kowanetz K, Soubeyran P, et al. (2002). “CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases”. J. Biol. Chem. 277 (42): 39666–72. doi:10.1074/jbc.M205535200. PMID 12177062.
- Courbard JR, Fiore F, Adélaïde J, et al. (2003). “Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH”. J. Biol. Chem. 277 (47): 45267–75. doi:10.1074/jbc.M206460200. PMID 12226085.
- Wong ES, Fong CW, Lim J, et al. (2002). “Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling”. EMBO J. 21 (18): 4796–808. doi:10.1093/emboj/cdf493. PMC 126289. PMID 12234920.
- Taher TE, Tjin EP, Beuling EA, et al. (2002). “C-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination”. J. Immunol. 169 (7): 3793–800. doi:10.4049/jimmunol.169.7.3793. PMID 12244174.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Nau MM, Lipkowitz S (2003). “Comparative genomic organization of the cbl genes”. Gene. 308: 103–13. doi:10.1016/S0378-1119(03)00471-2. PMID 12711395.
- Kim M, Tezuka T, Tanaka K, Yamamoto T (2004). “Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation”. Oncogene. 23 (9): 1645–55. doi:10.1038/sj.onc.1207298. PMID 14661060.
- Kassenbrock CK, Anderson SM (2004). “Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations”. J. Biol. Chem. 279 (27): 28017–27. doi:10.1074/jbc.M404114200. PMID 15117950.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. Bibcode:2004PNAS..10112130B. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514. S2CID 4427026.
Recent Comments